96 filings
D
VTYX
Ventyx Biosciences, Inc.
30 Sep 24
$27.00 mm in equity, sold $27.00 mm, 1 investor
4:40pm
8-K
VTYX
Ventyx Biosciences, Inc.
23 Sep 24
Entry into a Material Definitive Agreement
8:18am
8-K
VTYX
Ventyx Biosciences, Inc.
30 Aug 24
Departure of Directors or Certain Officers
8:15am
10-Q
2024 Q2
VTYX
Ventyx Biosciences, Inc.
Quarterly report
8 Aug 24
4:15pm
8-K
VTYX
Ventyx Biosciences, Inc.
8 Aug 24
Ventyx Biosciences Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Progress
4:05pm
8-K
2cqo16y7 hh
6 Jun 24
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
dmj qsk2k3k2
5 Jun 24
VTX3232 demonstrated improvements in body weight, systemic inflammatory biomarkers and cardiometabolic parameters in diet-induced obesity (DIO) mice
4:21pm
8-K
imljfk930 ujrkvr
16 May 24
Departure of Directors or Certain Officers
8:12am
8-K
1slrb
9 May 24
Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress
4:06pm
424B3
4dv ixqde
1 May 24
Prospectus supplement
4:06pm
EFFECT
6jah9uut1pmek
30 Apr 24
Notice of effectiveness
12:15am
EFFECT
3gnf6yntu b73q
29 Apr 24
Notice of effectiveness
12:15am
ARS
00nxoubzdzyi
25 Apr 24
Annual report to shareholders
4:19pm
DEFA14A
dpz0j7 bs
25 Apr 24
Additional proxy soliciting materials
4:10pm
S-3
7f04rs
9 Apr 24
Shelf registration
5:07pm
8-K
kqi9o3
5 Apr 24
Departure of Directors or Certain Officers
5:05pm
8-K
d2n2yq1n
11 Mar 24
Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides
9:01am
8-K
bs02mhso 53x
7 Mar 24
Ventyx Biosciences Announces $100 Million Private Placement of Common Stock
8:45am